Media Center
JCVI Will Be Collaborating with the University of California, Davis on a General Mills Funded Vanilla Genomics Project
J. Craig Venter Institute Signs MOU with University of Limpopo in South Africa to Extend Collaborations in South African Human Genomics and Prostate Cancer in Indigenous Populations
Two Institutions, along with the NIH National Institute of Allergy and Infectious Diseases, will Convene Conference on May 30-June 1, 2011 to Discuss Infectious Disease in South Africa
J. Craig Venter Institute Scientists, Along with International Team, Uncover New Insights into Evolution of Diatoms and Reveal Evidence for a Urea Cycle used to Metabolize Carbon and Nitrogen
JCVI's Synthetic Cell Named in MIT'S Technology Review as one of Ten Technologies Set to Transform our World
JCVI Construction of Synthetic Cell Named as Edison Award for 2011
Statement from J. Craig Venter, Ph.D., on the Presidential Commission for the Study of Bioethical Issues Report, "New Directions: The Ethics of Synthetic Biology and Emerging Technologies"
137 Marine Microbial Genomes from Cultured Samples are Sequenced and Compared to Sorcerer II Global Ocean Expedition Samples by Researchers at J. Craig Venter Institute
Research gives clearer picture of inhabitants living in ocean surface and gleans insights into how they adapt and survive
Exploring the World of Genomics and the Amazing Potential on the J. Craig Venter Institute's DiscoverGenomics! Mobile Lab at USA Science and Engineering Festival
Multimillion Dollar NIH Grant Pairs Venter Institute and the NYU College of Dentistry on Study to Predict Caries Risk
Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
SGVI announces collaboration with Novartis on the development of influenza vaccines using synthetic genomics technology Collaboration will combine advances in synthetic genomics science and genome sequencing capabilities with leading edge vaccine technology
Collaboration will combine advances in synthetic genomics science and genome sequencing capabilities with leading edge vaccine technology
Media Contact
Related
J. Robert Beyster and Life Technologies 2009-2010 Research Voyage Launch
After two years of intensive sampling in the waters off California and the west coast of the United States, the Sorcerer II Expedition embarked once again on March 21, 2009. Our destination: the Baltic, Black and Mediterranean Seas. Funded by generous donations from the Beyster Family Foundation...
The race to stop mirror organisms
If created, these versions of the building blocks of life could lead to environmental and ecological disaster
J. Craig Venter Describes a Human Genomics Revolution Still In Progress
Despite profound impact on bio-medical research, progress in understanding has been slow
Scientist renowned for study of adolescent brains named president of J. Craig Venter Institute
Anders Dale says he will move roughly $10 million in NIH funding from UCSD to JCVI.
Mirror Bacteria Research Poses Significant Risks, Dozens of Scientists Warn
Synthetic biologists make artificial cells, but one particular kind isn’t worth the risk.
Can CRISPR help stop African Swine Fever?
Gene editing could create a successful vaccine to protect against the viral disease that has killed close to 2 million pigs globally since 2021.
Getting Under the Skin
Amid an insulin crisis, one project aims to engineer microscopic insulin pumps out of a skin bacterium.
Planet Microbe
There are more organisms in the sea, a vital producer of oxygen on Earth, than planets and stars in the universe.
The Next Climate Change Calamity?: We’re Ruining the Microbiome, According to Human-Genome-Pioneer Craig Venter
In a new book (coauthored with Venter), a Vanity Fair contributor presents the oceanic evidence that human activity is altering the fabric of life on a microscopic scale.
Lessons from the Minimal Cell
“Despite reducing the sequence space of possible trajectories, we conclude that streamlining does not constrain fitness evolution and diversification of populations over time. Genome minimization may even create opportunities for evolutionary exploitation of essential genes, which are commonly observed to evolve more slowly.”
Logos
The JCVI logo is presented in two formats: stacked and inline. Both are acceptable, with no preference towards either. Any use of the J. Craig Venter Institute logo or name must be cleared through the JCVI Marketing and Communications team. Please submit requests to info@jcvi.org.
To download, choose a version below, right-click, and select “save link as” or similar.
Images
Following are images of our facilities, research areas, and staff for use in news media, education, and noncommercial applications, given attribution noted with each image. If you require something that is not provided or would like to use the image in a commercial application please reach out to the JCVI Marketing and Communications team at info@jcvi.org.